Cleared Traditional

THE IVY POLE-INTRAVENOUS BOT TREES #1121K & 1221K (K852937) - FDA 510(k) Clearance

Class I General Hospital device.

K852937 · Northern Customfab, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1985
Decision
16d
Days
Class 1
Risk

K852937 is an FDA 510(k) clearance for the THE IVY POLE-INTRAVENOUS BOT TREES #1121K & 1221K. Classified as Stand, Infusion (product code FOX), Class I - General Controls.

Submitted by Northern Customfab, Inc. (North Bay,Ont Plb 8k4 Ca, CA). The FDA issued a Cleared decision on July 26, 1985 after a review of 16 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6990 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Northern Customfab, Inc. devices

Submission Details

510(k) Number K852937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 1985
Decision Date July 26, 1985
Days to Decision 16 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
113d faster than avg
Panel avg: 129d · This submission: 16d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code FOX Stand, Infusion
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 880.6990
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.